Stock comparison
Becton, Dickinson and
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BDX
Becton, Dickinson and
Market cap
$53.46B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$44.06B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BDX | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 49D | 75B | IDXX |
| Benjamin Graham | 57C | 80A | IDXX |
| Philip Fisher | 36D | 75B | IDXX |
| Peter Lynch | 15F | 71B | IDXX |
| Joel Greenblatt | 40D | 83C | IDXX |
| Charlie Munger | 39D | 87A | IDXX |
| Terry Smith | 39D | 84A | IDXX |
Side-by-side metrics
| Metric | BDX | IDXX |
|---|---|---|
| Market cap | $53.46B | $44.06B |
| P/E (TTM) | 35.3x | 39.0x |
| EV/EBIT | 26.5x | 31.6x |
| ROIC (TTM) | 4.1% | 40.66% |
| Gross margin | 46.48% | 62.05% |
| Net margin | 5.33% | 24.63% |
| Revenue CAGR 5y | 3.37% | 7.56% |
| EPS CAGR 5y | -4.15% | 10.79% |
| Debt / Equity | 0.7x | 0.7x |
| Dividend yield | 2.45% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BDX leads on
- Dividend yield2.45%vs 0.0%+100%
- Market cap$53.46Bvs $44.06B+18%
- EV/EBIT26.5xvs 31.6x+16%
- P/E (TTM)35.3xvs 39.0x+9%
IDXX leads on
- EPS CAGR 5y10.79%vs -4.15%+138%
- ROIC (TTM)40.66%vs 4.1%+90%
- Net margin24.63%vs 5.33%+78%
- Revenue CAGR 5y7.56%vs 3.37%+55%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.